BNTX

WEEKLY STOCK MARKET DIGEST: MOMO STOCK BUYING ON POSITIVE SEASONALITY IGNORING THE FED AND INFLATION

By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules

Read More

CENTRAL BANK GOLD BUYING AT THE HIGHEST SINCE 1967, NONSENSICAL STOCK BUYING ON HOTTER JOBS REPORT

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Hotter Jobs Report Please click here for a chart of S&P 500 ETF (SPY) which represents the benchmark stock market index S&P 500 (SPX). Note the following: The chart shows there is buying

Read More

FED’S CLARIDA TALKS COMMON SENSE – WALL STREET RESPONDS BY SELLING STOCKS

By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know now. Selloff In Stocks On Common Sense Talk Please click here for a chart of Dow Jones Industrial Average ETF (DIA). Note the following: As we have been sharing with you this stock market

Read More

MORE GAINS AHEAD – 63% GAIN ON THIS SUPPLIER OF A KEY COMPONENT FOR VACCINE

  Maravai LifeSciences (MRVI) is long from $25.84.   MRVI is trading at $42.25 as of this writing.  This represents a gain of 63% in a short time. MRVI reported earnings significantly better than the consensus. We have previously written that the target zone was likely to be raised. MRVI supplies a key

Read More

CORONAVIRUS IS PROVIDING OPPORTUNITIES IN STOCKS YOU HAVE NEVER HEARD OF

Coronavirus is providing opportunities for investors beyond well-known names.  A good example is a stock that most investors have never heard of but have provided 38% return to The Arora Report subscribers in a short time.  More gains are likely ahead. The following post was published earlier on ZYX Buy.

Read More

WEEKLY STOCK MARKET DIGEST: PROTECT YOURSELF, POLITICIANS TURNING KING DOLLAR INTO POOR DOLLAR

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

A NEW IDEA ON BIOTECH MARAVAI — SUPPLIES A KEY COMPONENT OF CORONAVIRUS VACCINE

Maravai LifeSciences (MRVI) supplies a key component of the coronavirus vaccine produced by Pfizer (PFE) and BioNTech (BNTX). The vaccine should provide a sharp increase in revenue. The company also has a diversified product portfolio. Zones For those following the Good Way, the Buy Now rating is ‘YES.’ For those

Read More

WEEKLY STOCK MARKET DIGEST: AN IMPORTANT CHART THAT ALL INVESTORS SHOULD WATCH BUT ARE NOT WATCHING

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

VACCINE APPROVED IN U. K. — A VERY PROFITABLE SHORT TERM TRADE ON THE VACCINE STOCK MODERNA

The big news is that the vaccine from Pfizer (PFE) and BioNTech (BNTX) has been approved in the U. K. The vaccine is providing many long term investment opportunities and many short term trading opportunities. The Chart Please click here for a chart of vaccine maker Moderna (MRNA). Note the

Read More

WEEKLY STOCK MARKET DIGEST: MORE MONEY PRINTING AHEAD SAVES THE STOCK MARKET FROM A BIG DIP

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market

Read More

Do you want to gain an edge in the markets? Join thousands of your fellow investors and money managers to subscribe to Generate Wealth newsletter.

FREE FOREVER

Follow The Most Accurate Stock Market Analysis

Unrivaled Insights
In Bull and Bear Markets

Generate Wealth Newsletter
Free Forever

Generate Wealth Newsletter
Free Forever